Stock 7703 KAWASUMI LABORATORIES, INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Kawasumi Laboratories, Incorporated

Equities

7703

JP3225800006

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sumitomo Bakelite Company Limited completed the acquisition of an additional 65.99% stake in Kawasumi Laboratories, Incorporated from a group of shareholders for ¥25.7 billion.
CI
Sumitomo Bakelite Company Limited made an offer to acquire the remaining 76.95% stake in Kawasumi Laboratories, Incorporated from a group of shareholders for ¥27 billion.
CI
Ex-dividend day for extraordinary dividend
FA
Ex-dividend day for final dividend
FA
Kawasumi Laboratories, Incorporated Reports Consolidated Earnings Results for Nine Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020
CI
Kawasumi Laboratories, Incorporated Announces Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020; Announces Dividend for the Second Quarter Ended September 30, 2019, Payable on December 2, 2019; Provides Year End Dividend Guidance for the Year Ending March 31, 2020
CI
Ex-dividend day for interim dividend
FA
Kawasumi Laboratories, Incorporated Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter of Fiscal 2020 and for the Year Ending March 31, 2020
CI
Sumitomo Bakelite Company Limited completed the acquisition of 20.8% stake in Kawasumi Laboratories, Incorporated.
CI
Ex-dividend day for final dividend
FA
Sumitomo Bakelite Company Limited executed a capital and business alliance agreement to acquire 20.76% stake in Kawasumi Laboratories, Incorporated.
CI
Ex-dividend day for interim dividend
FA
Tranche Update on Kawasumi Laboratories, Incorporated's Equity Buyback Plan announced on August 9, 2018.
CI
Kawasumi Laboratories, Incorporated's Equity Buyback announced on August 9, 2018 has expired with 1,200,000 shares for ¥860.4 million.
CI
Kawasumi Laboratories, Incorporated announces an Equity Buyback for 1,300,000 shares, representing 5.96% for ¥932.1 million.
CI
Kawasumi Laboratories, Incorporated authorizes a Buyback Plan.
CI
Kawasumi Laboratories, Incorporated Announces Consolidated Earnings Results for the Year Ended March 31, 2018; Announces Dividend for the Year Ended March 31, 2018, Payable on June 22, 2018; Provides Earnings Guidance or the Year Ending March 31, 2019; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2019
CI
Ex-dividend day for final dividend
FA
Kawasumi Laboratories Inc. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Earnings and Dividend Guidance for the Year Ending March 31, 2018
CI
Kawasumi Laboratories Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Full Year of Fiscal Year Ending March 31, 2018
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 7703 Stock
  4. News Kawasumi Laboratories, Incorporated
  5. Highlights